Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project
Ahmedabad: Torrent Pharmaceuticals Limited announced that it has entered into a Share Subscription and Shareholders' Agreement (SSSA) to acquire a 26 percent equity stake in Torrent Urja 27 Private Limited, a step-down Subsidiary of the Company’s holding Company. The Transaction is being carried out at arm’s length basis.
Torrent Pharmaceuticals, headquartered in Ahmedabad, Gujarat, is a prominent Indian pharmaceutical company known for developing, manufacturing, and marketing branded and generic medications. It operates across various therapeutic areas, including cardiovascular, central nervous system, and diabetes care, with a strong presence in both regulated and emerging global markets.
Read also: Torrent Pharma seeks CCI clearance to acquire majority stake in JB Pharma in Rs 19500 crore deal
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.